Are you Dr. Nicodemus?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 59 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Unither
15walnut St, Ste300
Wellesley, MA 02481Phone+1 781-416-1506- Is this information wrong?
Summary
- Dr. Christopher Nicodemus, MD is a board certified internist in Wellesley, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Education & Training
Brigham and Women's HospitalFellowship, Allergy and Immunology, 1988 - 1990- Brigham and Women's HospitalFellowship, Rheumatology, 1987 - 1988
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1984 - 1987
SUNY Upstate Medical UniversityClass of 1984
Certifications & Licensure
MA State Medical License 1986 - 2025- American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer Start of enrollment: 2012 Jun 15
- The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer Start of enrollment: 2017 May 30
Publications & Presentations
PubMed
- 3 citationsIgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer.Spas Dimitrov Markov, Thomas C. Caffrey, Kelly A. O'Connell, James A. Grunkemeyer, Simon C. Shin, Ryan Hanson, Prathamesh Patil, Surendra K. Shukla, Daisy Gonzalez, Ay...> ;Molecular Cancer Therapeutics. 2021 Oct 8
- 2 citationsCorrection to: Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/pa...Alessandra Battaglia, Alexia Buzzonetti, Marco Fossati, Giovanni Scambia, Andrea Fattorossi, Madi Madiyalakan, Yolanda D. Mahnke, Christopher F. Nicodemus> ;Cancer Immunology, Immunotherapy. 2020 Jul 1
- 7 citationsTranslational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus o...Alessandra Battaglia, Alexia Buzzonetti, Marco Fossati, Giovanni Scambia, Andrea Fattorossi, Madi R Madiyalakan, Yolanda D Mahnke, Christopher Nicodemus> ;Cancer Immunology, Immunotherapy. 2020 Mar 1
- Join now to see all
